Global Bladder Cancer Therapeutics Industry

NEW YORK, Oct. 14, 2019 /PRNewswire/ --

Bladder Cancer Therapeutics market worldwide is projected to grow by US$89.9 Million, driven by a compounded growth of 4.8%. Transitional Cell Bladder Cancer, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$111.4 Million by the year 2025, Transitional Cell Bladder Cancer will bring in healthy gains adding significant momentum to global growth.

Read the full report: https://www.reportlinker.com/p05817906/?utm_source=PRN

- Representing the developed world, the United States will maintain a 3.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$3.2 Million to the region's size and clout in the next 5 to 6 years. Over US$2.6 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Transitional Cell Bladder Cancer will reach a market size of US$5.4 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.7% over the next couple of years and add approximately US$26.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, AstraZeneca plc; Bristol-Myers Squibb Company; Celgene Corporation; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Novartis International AG; Pfizer, Inc.



Read the full report: https://www.reportlinker.com/p05817906/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Bladder Cancer Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Bladder Cancer Therapeutics Global Market Estimates
and Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 2: Bladder Cancer Therapeutics Global Retrospective
Market Scenario in US$ Thousand by Region/Country: 2009-2017
Table 3: Bladder Cancer Therapeutics Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Transitional Cell Bladder Cancer (Type) World Market
by Region/Country in US$ Thousand: 2018 to 2025
Table 5: Transitional Cell Bladder Cancer (Type) Historic
Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
Table 6: Transitional Cell Bladder Cancer (Type) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 7: Non Muscle Invasive/Superficial Bladder Cancer (Type)
Potential Growth Markets Worldwide in US$ Thousand: 2018 to
2025
Table 8: Non Muscle Invasive/Superficial Bladder Cancer (Type)
Historic Market Perspective by Region/Country in US$ Thousand:
2009 to 2017
Table 9: Non Muscle Invasive/Superficial Bladder Cancer (Type)
Market Sales Breakdown by Region/Country in Percentage: 2009 VS
2019 VS 2025
Table 10: Invasive Bladder Cancer (Type) Geographic Market
Spread Worldwide in US$ Thousand: 2018 to 2025
Table 11: Invasive Bladder Cancer (Type) Region Wise Breakdown
of Global Historic Demand in US$ Thousand: 2009 to 2017
Table 12: Invasive Bladder Cancer (Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 13: Squamous Cell Bladder Cancer (Type) World Market
Estimates and Forecasts by Region/Country in US$ Thousand: 2018
to 2025
Table 14: Squamous Cell Bladder Cancer (Type) Market Historic
Review by Region/Country in US$ Thousand: 2009 to 2017
Table 15: Squamous Cell Bladder Cancer (Type) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 16: Adenocarcinoma of the Bladder (Type) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 17: Adenocarcinoma of the Bladder (Type) Historic Market
Analysis by Region/Country in US$ Thousand: 2009 to 2017
Table 18: Adenocarcinoma of the Bladder (Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 19: Rare Bladder Cancers (Type) World Market Estimates
and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
Table 20: Rare Bladder Cancers (Type) Market Worldwide Historic
Review by Region/Country in US$ Thousand: 2009 to 2017
Table 21: Rare Bladder Cancers (Type) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 22: Surgery (Treatment) Market Opportunity Analysis
Worldwide in US$ Thousand by Region/Country: 2018 to 2025
Table 23: Surgery (Treatment) Global Historic Demand in US$
Thousand by Region/Country: 2009 to 2017
Table 24: Surgery (Treatment) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 25: Chemotherapy (Treatment) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 26: Chemotherapy (Treatment) Historic Market Analysis by
Region/Country in US$ Thousand: 2009 to 2017
Table 27: Chemotherapy (Treatment) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 28: Immunotherapy (Treatment) Potential Growth Markets
Worldwide in US$ Thousand: 2018 to 2025
Table 29: Immunotherapy (Treatment) Historic Market Perspective
by Region/Country in US$ Thousand: 2009 to 2017
Table 30: Immunotherapy (Treatment) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 31: Radiation Therapy (Treatment) Geographic Market
Spread Worldwide in US$ Thousand: 2018 to 2025
Table 32: Radiation Therapy (Treatment) Region Wise Breakdown
of Global Historic Demand in US$ Thousand: 2009 to 2017
Table 33: Radiation Therapy (Treatment) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 34: Intravesical Therapy (Treatment) World Market
Estimates and Forecasts by Region/Country in US$ Thousand: 2018
to 2025
Table 35: Intravesical Therapy (Treatment) Market Historic
Review by Region/Country in US$ Thousand: 2009 to 2017
Table 36: Intravesical Therapy (Treatment) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Bladder Cancer Therapeutics Market Share (in %) by Company:
2019 & 2025
Table 37: United States Bladder Cancer Therapeutics Market
Estimates and Projections in US$ Thousand by Type: 2018 to 2025
Table 38: Bladder Cancer Therapeutics Market in the United
States by Type: A Historic Review in US$ Thousand for 2009-2017
Table 39: United States Bladder Cancer Therapeutics Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 40: United States Bladder Cancer Therapeutics Market
Estimates and Projections in US$ Thousand by Treatment: 2018 to
2025
Table 41: Bladder Cancer Therapeutics Market in the United
States by Treatment: A Historic Review in US$ Thousand for
2009-2017
Table 42: United States Bladder Cancer Therapeutics Market
Share Breakdown by Treatment: 2009 VS 2019 VS 2025
CANADA
Table 43: Canadian Bladder Cancer Therapeutics Market Estimates
and Forecasts in US$ Thousand by Type: 2018 to 2025
Table 44: Canadian Bladder Cancer Therapeutics Historic Market
Review by Type in US$ Thousand: 2009-2017
Table 45: Bladder Cancer Therapeutics Market in Canada:
Percentage Share Breakdown of Sales by Type for 2009, 2019, and
2025
Table 46: Canadian Bladder Cancer Therapeutics Market Estimates
and Forecasts in US$ Thousand by Treatment: 2018 to 2025
Table 47: Canadian Bladder Cancer Therapeutics Historic Market
Review by Treatment in US$ Thousand: 2009-2017
Table 48: Bladder Cancer Therapeutics Market in Canada:
Percentage Share Breakdown of Sales by Treatment for 2009,
2019, and 2025
JAPAN
Table 49: Japanese Market for Bladder Cancer Therapeutics:
Annual Sales Estimates and Projections in US$ Thousand by Type
for the Period 2018-2025
Table 50: Bladder Cancer Therapeutics Market in Japan: Historic
Sales Analysis in US$ Thousand by Type for the Period 2009-2017
Table 51: Japanese Bladder Cancer Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 52: Japanese Market for Bladder Cancer Therapeutics:
Annual Sales Estimates and Projections in US$ Thousand by
Treatment for the Period 2018-2025
Table 53: Bladder Cancer Therapeutics Market in Japan: Historic
Sales Analysis in US$ Thousand by Treatment for the Period
2009-2017
Table 54: Japanese Bladder Cancer Therapeutics Market Share
Analysis by Treatment: 2009 VS 2019 VS 2025
CHINA
Table 55: Chinese Bladder Cancer Therapeutics Market Growth
Prospects in US$ Thousand by Type for the Period 2018-2025
Table 56: Bladder Cancer Therapeutics Historic Market Analysis
in China in US$ Thousand by Type: 2009-2017
Table 57: Chinese Bladder Cancer Therapeutics Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 58: Chinese Bladder Cancer Therapeutics Market Growth
Prospects in US$ Thousand by Treatment for the Period 2018-2025
Table 59: Bladder Cancer Therapeutics Historic Market Analysis
in China in US$ Thousand by Treatment: 2009-2017
Table 60: Chinese Bladder Cancer Therapeutics Market by
Treatment: Percentage Breakdown of Sales for 2009, 2019, and
2025
EUROPE
Market Facts & Figures
European Bladder Cancer Therapeutics Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 61: European Bladder Cancer Therapeutics Market Demand
Scenario in US$ Thousand by Region/Country: 2018-2025
Table 62: Bladder Cancer Therapeutics Market in Europe: A
Historic Market Perspective in US$ Thousand by Region/Country
for the Period 2009-2017
Table 63: European Bladder Cancer Therapeutics Market Share
Shift by Region/Country: 2009 VS 2019 VS 2025
Table 64: European Bladder Cancer Therapeutics Market Estimates
and Forecasts in US$ Thousand by Type: 2018-2025
Table 65: Bladder Cancer Therapeutics Market in Europe in US$
Thousand by Type: A Historic Review for the Period 2009-2017
Table 66: European Bladder Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 67: European Bladder Cancer Therapeutics Market Estimates
and Forecasts in US$ Thousand by Treatment: 2018-2025
Table 68: Bladder Cancer Therapeutics Market in Europe in US$
Thousand by Treatment: A Historic Review for the Period
2009-2017
Table 69: European Bladder Cancer Therapeutics Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
FRANCE
Table 70: Bladder Cancer Therapeutics Market in France by Type:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 71: French Bladder Cancer Therapeutics Historic Market
Scenario in US$ Thousand by Type: 2009-2017
Table 72: French Bladder Cancer Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 73: Bladder Cancer Therapeutics Market in France by
Treatment: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 74: French Bladder Cancer Therapeutics Historic Market
Scenario in US$ Thousand by Treatment: 2009-2017
Table 75: French Bladder Cancer Therapeutics Market Share
Analysis by Treatment: 2009 VS 2019 VS 2025
GERMANY
Table 76: Bladder Cancer Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Thousand by Type for
the Period 2018-2025
Table 77: German Bladder Cancer Therapeutics Historic Market
Analysis in US$ Thousand by Type: 2009-2017
Table 78: German Bladder Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 79: Bladder Cancer Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Thousand by Treatment
for the Period 2018-2025
Table 80: German Bladder Cancer Therapeutics Historic Market
Analysis in US$ Thousand by Treatment: 2009-2017
Table 81: German Bladder Cancer Therapeutics Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
ITALY
Table 82: Italian Bladder Cancer Therapeutics Market Growth
Prospects in US$ Thousand by Type for the Period 2018-2025
Table 83: Bladder Cancer Therapeutics Historic Market Analysis
in Italy in US$ Thousand by Type: 2009-2017
Table 84: Italian Bladder Cancer Therapeutics Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 85: Italian Bladder Cancer Therapeutics Market Growth
Prospects in US$ Thousand by Treatment for the Period 2018-2025
Table 86: Bladder Cancer Therapeutics Historic Market Analysis
in Italy in US$ Thousand by Treatment: 2009-2017
Table 87: Italian Bladder Cancer Therapeutics Market by
Treatment: Percentage Breakdown of Sales for 2009, 2019, and
2025
UNITED KINGDOM
Table 88: United Kingdom Market for Bladder Cancer
Therapeutics: Annual Sales Estimates and Projections in US$
Thousand by Type for the Period 2018-2025
Table 89: Bladder Cancer Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Thousand by Type for
the Period 2009-2017
Table 90: United Kingdom Bladder Cancer Therapeutics Market
Share Analysis by Type: 2009 VS 2019 VS 2025
Table 91: United Kingdom Market for Bladder Cancer
Therapeutics: Annual Sales Estimates and Projections in US$
Thousand by Treatment for the Period 2018-2025
Table 92: Bladder Cancer Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Thousand by Treatment
for the Period 2009-2017
Table 93: United Kingdom Bladder Cancer Therapeutics Market
Share Analysis by Treatment: 2009 VS 2019 VS 2025
SPAIN
Table 94: Spanish Bladder Cancer Therapeutics Market Estimates
and Forecasts in US$ Thousand by Type: 2018 to 2025
Table 95: Spanish Bladder Cancer Therapeutics Historic Market
Review by Type in US$ Thousand: 2009-2017
Table 96: Bladder Cancer Therapeutics Market in Spain:
Percentage Share Breakdown of Sales by Type for 2009, 2019, and
2025
Table 97: Spanish Bladder Cancer Therapeutics Market Estimates
and Forecasts in US$ Thousand by Treatment: 2018 to 2025
Table 98: Spanish Bladder Cancer Therapeutics Historic Market
Review by Treatment in US$ Thousand: 2009-2017
Table 99: Bladder Cancer Therapeutics Market in Spain:
Percentage Share Breakdown of Sales by Treatment for 2009,
2019, and 2025
RUSSIA
Table 100: Russian Bladder Cancer Therapeutics Market Estimates
and Projections in US$ Thousand by Type: 2018 to 2025
Table 101: Bladder Cancer Therapeutics Market in Russia by
Type: A Historic Review in US$ Thousand for 2009-2017
Table 102: Russian Bladder Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 103: Russian Bladder Cancer Therapeutics Market Estimates
and Projections in US$ Thousand by Treatment: 2018 to 2025
Table 104: Bladder Cancer Therapeutics Market in Russia by
Treatment: A Historic Review in US$ Thousand for 2009-2017
Table 105: Russian Bladder Cancer Therapeutics Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 106: Rest of Europe Bladder Cancer Therapeutics Market
Estimates and Forecasts in US$ Thousand by Type: 2018-2025
Table 107: Bladder Cancer Therapeutics Market in Rest of Europe
in US$ Thousand by Type: A Historic Review for the Period
2009-2017
Table 108: Rest of Europe Bladder Cancer Therapeutics Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 109: Rest of Europe Bladder Cancer Therapeutics Market
Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
Table 110: Bladder Cancer Therapeutics Market in Rest of Europe
in US$ Thousand by Treatment: A Historic Review for the Period
2009-2017
Table 111: Rest of Europe Bladder Cancer Therapeutics Market
Share Breakdown by Treatment: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 112: Asia-Pacific Bladder Cancer Therapeutics Market
Estimates and Forecasts in US$ Thousand by Region/Country:
2018-2025
Table 113: Bladder Cancer Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Thousand by Region/Country for
the Period 2009-2017
Table 114: Asia-Pacific Bladder Cancer Therapeutics Market
Share Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 115: Bladder Cancer Therapeutics Market in Asia-Pacific
by Type: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 116: Asia-Pacific Bladder Cancer Therapeutics Historic
Market Scenario in US$ Thousand by Type: 2009-2017
Table 117: Asia-Pacific Bladder Cancer Therapeutics Market
Share Analysis by Type: 2009 VS 2019 VS 2025
Table 118: Bladder Cancer Therapeutics Market in Asia-Pacific
by Treatment: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 119: Asia-Pacific Bladder Cancer Therapeutics Historic
Market Scenario in US$ Thousand by Treatment: 2009-2017
Table 120: Asia-Pacific Bladder Cancer Therapeutics Market
Share Analysis by Treatment: 2009 VS 2019 VS 2025
AUSTRALIA
Table 121: Bladder Cancer Therapeutics Market in Australia:
Recent Past, Current and Future Analysis in US$ Thousand by
Type for the Period 2018-2025
Table 122: Australian Bladder Cancer Therapeutics Historic
Market Analysis in US$ Thousand by Type: 2009-2017
Table 123: Australian Bladder Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 124: Bladder Cancer Therapeutics Market in Australia:
Recent Past, Current and Future Analysis in US$ Thousand by
Treatment for the Period 2018-2025
Table 125: Australian Bladder Cancer Therapeutics Historic
Market Analysis in US$ Thousand by Treatment: 2009-2017
Table 126: Australian Bladder Cancer Therapeutics Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
INDIA
Table 127: Indian Bladder Cancer Therapeutics Market Estimates
and Forecasts in US$ Thousand by Type: 2018 to 2025
Table 128: Indian Bladder Cancer Therapeutics Historic Market
Review by Type in US$ Thousand: 2009-2017
Table 129: Bladder Cancer Therapeutics Market in India:
Percentage Share Breakdown of Sales by Type for 2009, 2019, and
2025
Table 130: Indian Bladder Cancer Therapeutics Market Estimates
and Forecasts in US$ Thousand by Treatment: 2018 to 2025
Table 131: Indian Bladder Cancer Therapeutics Historic Market
Review by Treatment in US$ Thousand: 2009-2017
Table 132: Bladder Cancer Therapeutics Market in India:
Percentage Share Breakdown of Sales by Treatment for 2009,
2019, and 2025
SOUTH KOREA
Table 133: Bladder Cancer Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Thousand by
Type for the Period 2018-2025
Table 134: South Korean Bladder Cancer Therapeutics Historic
Market Analysis in US$ Thousand by Type: 2009-2017
Table 135: Bladder Cancer Therapeutics Market Share
Distribution in South Korea by Type: 2009 VS 2019 VS 2025
Table 136: Bladder Cancer Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Thousand by
Treatment for the Period 2018-2025
Table 137: South Korean Bladder Cancer Therapeutics Historic
Market Analysis in US$ Thousand by Treatment: 2009-2017
Table 138: Bladder Cancer Therapeutics Market Share
Distribution in South Korea by Treatment: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 139: Rest of Asia-Pacific Market for Bladder Cancer
Therapeutics: Annual Sales Estimates and Projections in US$
Thousand by Type for the Period 2018-2025
Table 140: Bladder Cancer Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Thousand by Type
for the Period 2009-2017
Table 141: Rest of Asia-Pacific Bladder Cancer Therapeutics
Market Share Analysis by Type: 2009 VS 2019 VS 2025
Table 142: Rest of Asia-Pacific Market for Bladder Cancer
Therapeutics: Annual Sales Estimates and Projections in US$
Thousand by Treatment for the Period 2018-2025
Table 143: Bladder Cancer Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Thousand by
Treatment for the Period 2009-2017
Table 144: Rest of Asia-Pacific Bladder Cancer Therapeutics
Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 145: Latin American Bladder Cancer Therapeutics Market
Trends by Region/Country in US$ Thousand: 2018-2025
Table 146: Bladder Cancer Therapeutics Market in Latin America
in US$ Thousand by Region/Country: A Historic Perspective for
the Period 2009-2017
Table 147: Latin American Bladder Cancer Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 148: Latin American Bladder Cancer Therapeutics Market
Growth Prospects in US$ Thousand by Type for the Period
2018-2025
Table 149: Bladder Cancer Therapeutics Historic Market Analysis
in Latin America in US$ Thousand by Type: 2009-2017
Table 150: Latin American Bladder Cancer Therapeutics Market
by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 151: Latin American Bladder Cancer Therapeutics Market
Growth Prospects in US$ Thousand by Treatment for the Period
2018-2025
Table 152: Bladder Cancer Therapeutics Historic Market Analysis
in Latin America in US$ Thousand by Treatment: 2009-2017
Table 153: Latin American Bladder Cancer Therapeutics Market
by Treatment: Percentage Breakdown of Sales for 2009, 2019, and
2025
ARGENTINA
Table 154: Argentinean Bladder Cancer Therapeutics Market
Estimates and Forecasts in US$ Thousand by Type: 2018-2025
Table 155: Bladder Cancer Therapeutics Market in Argentina in
US$ Thousand by Type: A Historic Review for the Period
2009-2017
Table 156: Argentinean Bladder Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 157: Argentinean Bladder Cancer Therapeutics Market
Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
Table 158: Bladder Cancer Therapeutics Market in Argentina in
US$ Thousand by Treatment: A Historic Review for the Period
2009-2017
Table 159: Argentinean Bladder Cancer Therapeutics Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
BRAZIL
Table 160: Bladder Cancer Therapeutics Market in Brazil by
Type: Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 161: Brazilian Bladder Cancer Therapeutics Historic
Market Scenario in US$ Thousand by Type: 2009-2017
Table 162: Brazilian Bladder Cancer Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 163: Bladder Cancer Therapeutics Market in Brazil by
Treatment: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 164: Brazilian Bladder Cancer Therapeutics Historic
Market Scenario in US$ Thousand by Treatment: 2009-2017
Table 165: Brazilian Bladder Cancer Therapeutics Market Share
Analysis by Treatment: 2009 VS 2019 VS 2025
MEXICO
Table 166: Bladder Cancer Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Thousand by Type for
the Period 2018-2025
Table 167: Mexican Bladder Cancer Therapeutics Historic Market
Analysis in US$ Thousand by Type: 2009-2017
Table 168: Mexican Bladder Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 169: Bladder Cancer Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Thousand by Treatment
for the Period 2018-2025
Table 170: Mexican Bladder Cancer Therapeutics Historic Market
Analysis in US$ Thousand by Treatment: 2009-2017
Table 171: Mexican Bladder Cancer Therapeutics Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 172: Rest of Latin America Bladder Cancer Therapeutics
Market Estimates and Projections in US$ Thousand by Type: 2018
to 2025
Table 173: Bladder Cancer Therapeutics Market in Rest of Latin
America by Type: A Historic Review in US$ Thousand for
2009-2017
Table 174: Rest of Latin America Bladder Cancer Therapeutics
Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 175: Rest of Latin America Bladder Cancer Therapeutics
Market Estimates and Projections in US$ Thousand by Treatment:
2018 to 2025
Table 176: Bladder Cancer Therapeutics Market in Rest of Latin
America by Treatment: A Historic Review in US$ Thousand for
2009-2017
Table 177: Rest of Latin America Bladder Cancer Therapeutics
Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 178: The Middle East Bladder Cancer Therapeutics Market
Estimates and Forecasts in US$ Thousand by Region/Country:
2018-2025
Table 179: Bladder Cancer Therapeutics Market in the Middle
East by Region/Country in US$ Thousand: 2009-2017
Table 180: The Middle East Bladder Cancer Therapeutics Market
Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 181: The Middle East Bladder Cancer Therapeutics Market
Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
Table 182: The Middle East Bladder Cancer Therapeutics Historic
Market by Type in US$ Thousand: 2009-2017
Table 183: Bladder Cancer Therapeutics Market in the Middle
East: Percentage Share Breakdown of Sales by Type for 2009,
2019, and 2025
Table 184: The Middle East Bladder Cancer Therapeutics Market
Estimates and Forecasts in US$ Thousand by Treatment: 2018 to
2025
Table 185: The Middle East Bladder Cancer Therapeutics Historic
Market by Treatment in US$ Thousand: 2009-2017
Table 186: Bladder Cancer Therapeutics Market in the Middle
East: Percentage Share Breakdown of Sales by Treatment for
2009, 2019, and 2025
IRAN
Table 187: Iranian Market for Bladder Cancer Therapeutics:
Annual Sales Estimates and Projections in US$ Thousand by Type
for the Period 2018-2025
Table 188: Bladder Cancer Therapeutics Market in Iran: Historic
Sales Analysis in US$ Thousand by Type for the Period 2009-2017
Table 189: Iranian Bladder Cancer Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 190: Iranian Market for Bladder Cancer Therapeutics:
Annual Sales Estimates and Projections in US$ Thousand by
Treatment for the Period 2018-2025
Table 191: Bladder Cancer Therapeutics Market in Iran: Historic
Sales Analysis in US$ Thousand by Treatment for the Period
2009-2017
Table 192: Iranian Bladder Cancer Therapeutics Market Share
Analysis by Treatment: 2009 VS 2019 VS 2025
ISRAEL
Table 193: Israeli Bladder Cancer Therapeutics Market Estimates
and Forecasts in US$ Thousand by Type: 2018-2025
Table 194: Bladder Cancer Therapeutics Market in Israel in US$
Thousand by Type: A Historic Review for the Period 2009-2017
Table 195: Israeli Bladder Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 196: Israeli Bladder Cancer Therapeutics Market Estimates
and Forecasts in US$ Thousand by Treatment: 2018-2025
Table 197: Bladder Cancer Therapeutics Market in Israel in US$
Thousand by Treatment: A Historic Review for the Period
2009-2017
Table 198: Israeli Bladder Cancer Therapeutics Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 199: Saudi Arabian Bladder Cancer Therapeutics Market
Growth Prospects in US$ Thousand by Type for the Period
2018-2025
Table 200: Bladder Cancer Therapeutics Historic Market Analysis
in Saudi Arabia in US$ Thousand by Type: 2009-2017
Table 201: Saudi Arabian Bladder Cancer Therapeutics Market by
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 202: Saudi Arabian Bladder Cancer Therapeutics Market
Growth Prospects in US$ Thousand by Treatment for the Period
2018-2025
Table 203: Bladder Cancer Therapeutics Historic Market Analysis
in Saudi Arabia in US$ Thousand by Treatment: 2009-2017
Table 204: Saudi Arabian Bladder Cancer Therapeutics Market by
Treatment: Percentage Breakdown of Sales for 2009, 2019, and
2025
UNITED ARAB EMIRATES
Table 205: Bladder Cancer Therapeutics Market in the United
Arab Emirates: Recent Past, Current and Future Analysis in US$
Thousand by Type for the Period 2018-2025
Table 206: United Arab Emirates Bladder Cancer Therapeutics
Historic Market Analysis in US$ Thousand by Type: 2009-2017
Table 207: Bladder Cancer Therapeutics Market Share
Distribution in United Arab Emirates by Type: 2009 VS 2019 VS
2025
Table 208: Bladder Cancer Therapeutics Market in the United
Arab Emirates: Recent Past, Current and Future Analysis in US$
Thousand by Treatment for the Period 2018-2025
Table 209: United Arab Emirates Bladder Cancer Therapeutics
Historic Market Analysis in US$ Thousand by Treatment:
2009-2017
Table 210: Bladder Cancer Therapeutics Market Share
Distribution in United Arab Emirates by Treatment: 2009 VS 2019
VS 2025
REST OF MIDDLE EAST
Table 211: Bladder Cancer Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Thousand
by Type for the Period 2018-2025
Table 212: Rest of Middle East Bladder Cancer Therapeutics
Historic Market Analysis in US$ Thousand by Type: 2009-2017
Table 213: Rest of Middle East Bladder Cancer Therapeutics
Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 214: Bladder Cancer Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Thousand
by Treatment for the Period 2018-2025
Table 215: Rest of Middle East Bladder Cancer Therapeutics
Historic Market Analysis in US$ Thousand by Treatment:
2009-2017
Table 216: Rest of Middle East Bladder Cancer Therapeutics
Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
AFRICA
Table 217: African Bladder Cancer Therapeutics Market Estimates
and Projections in US$ Thousand by Type: 2018 to 2025
Table 218: Bladder Cancer Therapeutics Market in Africa by
Type: A Historic Review in US$ Thousand for 2009-2017
Table 219: African Bladder Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 220: African Bladder Cancer Therapeutics Market Estimates
and Projections in US$ Thousand by Treatment: 2018 to 2025
Table 221: Bladder Cancer Therapeutics Market in Africa by
Treatment: A Historic Review in US$ Thousand for 2009-2017
Table 222: African Bladder Cancer Therapeutics Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025

IV. COMPETITION

ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB COMPANY
CELGENE CORPORATION
ELI LILLY AND COMPANY
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
NOVARTIS INTERNATIONAL AG
PFIZER

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817906/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/global-bladder-cancer-therapeutics-industry-300937803.html

SOURCE Reportlinker